23 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
, these laws include, without limitation, state and federal anti-kickback, false claims, physician transparency and patient data privacy and security … things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs and reform government
ARS
o6peqkdmtcv
28 Apr 23
Annual report to shareholders
7:03am
424B4
317gla a4
21 Jun 21
Prospectus supplement with pricing info
8:08am
DRS
2szm77
19 May 21
Draft registration statement
12:00am
10-K
lbhsbw5 s8
11 Mar 21
Annual report
4:19pm
10-Q
hnzdh7ltygz9r sf2w5
12 Nov 20
Quarterly report
4:28pm
424B4
nof1c837bhn4dz
2 Oct 20
Prospectus supplement with pricing info
5:10pm